Israeli stocks on Wall St

Israeli stocks on Wall St

  
Search Globes Online archive


11939 results found for 'Israeli stocks on Wall St'. Results 1 - 10 displayed
119,055 articles in Globes Archive

Subscribe to the Globes Archive

1

Gazit-Globe to delist Gazit America

Israeli stocks on Wall St
  Gazit-Globe Gazit America will offer to buy 73.1% of Gazit America at C$7.07 per share in cash and First Capital Realty shares.
  Globes' correspondent 06/05/2012
 Gazit-Globe Ltd. (NYSE: GZT ; TASE: GLOB ) and its Canadian subsidiary First Capital Realty Inc. (TSX: FCR ) plan to delist Gazit America Inc. (TSX: GAA ). Gazit-Globe currently owns 26.9% of Gazit ...
2

Strong recommendation for Nova after financials

Israeli stocks on Wall St
  Needham & Company has reiterated its "Strong Buy" rating.
  Hillel Koren 03/05/2012
 Nova Measuring Instruments Ltd. (Nasdaq: NVMI ; TASE: NVMI )reported first quarter financial results yesterday, and has received a reiterated "Strong Buy" recommendation from Needham & Company today....
3

Tower teams with female Haredi initiative Rachip

Israeli stocks on Wall St
  The partnership will provide Tower with external solutions and services to assist its customers with CAD, QA and run-set development.
  Globes correspondent 03/05/2012
 Specialty foundry Tower Semiconductor Ltd. (Nasdaq: TSEM ; TASE: TSEM ), which markets under the name TowerJazz, today said that it is partnering with Rachip. The partnership will provide Tower with ...
4

Maiman files for arbitration over Egyptian gas

Israeli stocks on Wall St
  Ampal is seeking financial compensation for what it terms "Egypt's treaty violations."
  Yossi Nissan 03/05/2012
 Ampal-American Israel Corporation (Nasdaq: AMPL ; TASE: AMPL ), controlled by Yosef Maiman, today said that it has filed a request for arbitration against the Egyptian government, in connection with ...
5

Analysts see huge upside in Protalix after FDA approval

Israeli stocks on Wall St
  Harel sees a 45% premium on yesterday's share price and Oppenheimer sees a 60% premium.
  Koby Yeshayahou and Guy 02/05/2012
 Analysts see a huge upside in Protalix Biotherapeutics Inc. (AMEX: PLX ; TASE: PLX ) share price after the drug development company received FDA approval to market its Elelyso treatment for Gaucher (...
6

Gilat wins follow-on South East Asian deal

Israeli stocks on Wall St
  Gilat has been selected by a Tier-1 Mobile Network Operator (MNO) in South East Asia to provide its SkyEdge II network for GSM and 3G cellular backhaul.
  Globes correspondent 02/05/2012
 Gilat Satellite Networks Ltd. (Nasdaq: GILT ; TASE: GILT ) announced it has been selected by a Tier-1 Mobile Network Operator (MNO) in South East Asia to provide its SkyEdge II network for GSM and 3G...
7

Delta buys German underwear co Schiesser

Israeli stocks on Wall St
  Schiesser AG, which had revenue of €68 million last year, is in the process of being liquidated.
  Globes correspondent 02/05/2012
 Delta Galil Industries Ltd. (Pink Sheet: DELTY ; TASE: DELT ) has announced that it is acquiring German underwear manufacturer Schiesser AG for €68 million. Schiesser, which designs, develops, Delta...
8

Amdocs to pay dividend on higher profit, revenue

Israeli stocks on Wall St
  The billing and business support systems company also raised its earnings per share guidance but lowered revenue guidance.
  Hillel Koren 02/05/2012
 Amdocs Ltd. (NYSE: DOX ) CEO Eli Gelman said the company will pay a dividend after the billing and business support systems company reported revenue and profit growth and higher earnings per share for...
9

FDA approves Protalix Gaucher treatment

Israeli stocks on Wall St
  Protalix is to receive a $25 million milestone payment from Pfizer, which developed the treatment with the Israeli company.
  Gali Weinreb and Koby 02/05/2012
 The US Food and Drug Administration (FDA) has approved for marketing in the US Protalix Biotherapeutics Inc. (AMEX: PLX ; TASE: PLX ) drug Elelyso for the treatment of Gaucher disease. The approval ...
10

Stem cell co Pluristem awarded $3.1m chief scientist grant

Israeli stocks on Wall St
  The grant will be used for R&D and clinical trials of product candidates.
  Globes correspondent 01/05/2012
 Stem cell company Pluristem Therapeutics Ltd. (Nasdaq: PSTI ; DAX: PJT: PLTR ) says that its subsidiary Pluristem Ltd., has received approval for a NIS11.8 million ($3.1 million) grant from the Office...

12345678910